IL9 and systemic sclerosis: The results showed that IL-17 and SSc serum significantly promoted the secretion of IL-9 by immature T lymphocytes, while IL-17 neutralizing antibody and tanshinone IIA significantly inhibited the secretion of IL-9 by immature T-lymphocytes and reversed the promoting effect of IL-17 and SSc serum (Fig. 5C).